{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T04:09:48Z","timestamp":1785125388618,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T00:00:00Z","timestamp":1511136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Instituto Nacional de Pediatr\u00eda","award":["024\/2016"],"award-info":[{"award-number":["024\/2016"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ijpddr.2017.11.003","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T08:36:20Z","timestamp":1512117380000},"page":"425-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Disulfiram as a novel inactivator of Giardia lamblia triosephosphate isomerase with antigiardial potential"],"prefix":"10.1016","volume":"7","author":[{"given":"Adriana","family":"Castillo-Villanueva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadira","family":"Rufino-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara-Teresa","family":"M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lica","family":"Torres-Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Ponce-Macotela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario No\u00e9","family":"Mart\u00ednez-Gordillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio","family":"Reyes-Vivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Oria-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2017.11.003_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/CMR.14.3.447-475.2001","article-title":"Biology of Giardia lamblia","volume":"14","author":"Adam","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib2","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.biotechadv.2015.04.009","article-title":"Drug resistance in Giardia duodenalis","volume":"33","author":"Ansell","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1743-422X-7-20","article-title":"Inactivation of respiratory syncytial virus by zinc finger reactive compounds","volume":"7","author":"Boukhvalova","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib4","first-page":"273","article-title":"The old and new therapeutic approaches to the treatment of giardiasis: where are we?","volume":"3","author":"Busatti","year":"2009","journal-title":"Biologics"},{"key":"10.1016\/j.ijpddr.2017.11.003_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.18773\/austprescr.2015.015","article-title":"Long-term drug treatment of patients with alcohol dependence","volume":"38","author":"Crowley","year":"2015","journal-title":"Aust. Prescr."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib6","doi-asserted-by":"crossref","first-page":"e0123379","DOI":"10.1371\/journal.pone.0123379","article-title":"Structural effects of protein aging: terminal marking by deamidation in human triosephosphate isomerase","volume":"10","author":"de la Mora-de la Mora","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2017.11.003_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molbiopara.2007.10.013","article-title":"Species-specific inhibition of Giardia lamblia triosephosphate isomerase by localized perturbation of the homodimer","volume":"157","author":"Enriquez-Flores","year":"2008","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib8","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1002\/prot.23100","article-title":"Determining the molecular mechanism of inactivation by chemical modification of triosephosphate isomerase from the human parasite Giardia lamblia: a study for antiparasitic drug design","volume":"79","author":"Enr\u00edquez-Flores","year":"2011","journal-title":"Proteins"},{"key":"10.1016\/j.ijpddr.2017.11.003_bib9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1128\/CMR.00033-10","article-title":"Zoonotic potential and molecular epidemiology of Giardia species and giardiasis","volume":"24","author":"Feng","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib10","doi-asserted-by":"crossref","first-page":"10502","DOI":"10.1074\/jbc.M114.553123","article-title":"Structural basis for inactivation of Giardia lamblia carbamate kinase by disulfiram","volume":"289","author":"Galkin","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib11","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1074\/jbc.M609534200","article-title":"Characterization, kinetics, and crystal structures of fructose-1,6-bisphosphate aldolase from the human parasite, Giardia lamblia","volume":"282","author":"Galkin","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbagen.2015.10.021","article-title":"Proton pump inhibitors drastically modify triosephosphate isomerase from Giardia lamblia at functional and structural levels, providing molecular leads in the design of new antigiardiasic drugs","volume":"1860","author":"Gadrc\u00eda-Torres","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpddr.2017.11.003_bib13","series-title":"Current Topics of Drug Design in Parasitic and Bacterial Diseases","first-page":"49","article-title":"Novel therapeutic approaches for protozoan parasitic diseases","author":"Garc\u00eda-Torres","year":"2012"},{"key":"10.1016\/j.ijpddr.2017.11.003_bib14","doi-asserted-by":"crossref","first-page":"e69031","DOI":"10.1371\/journal.pone.0069031","article-title":"Structural and functional perturbation of Giardia lamblia triosephosphate isomerase by modification of a non-catalytic, non-conserved region","volume":"8","author":"Hern\u00e1ndez-Alc\u00e1ntara","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2017.11.003_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0166-6851(99)00145-0","article-title":"Purification and characterization of recombinant pyruvate phosphate dikinase from Giardia","volume":"104","author":"Hiltpold","year":"1999","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/156800911794519798","article-title":"Disulfiram, and disulfiram derivatives as novel potential anticancer drugs targeting the ubiquitin-proteasome system in both preclinical and clinical studies","volume":"11","author":"Kona","year":"2011","journal-title":"Curr. Cancer Drug. Targets"},{"key":"10.1016\/j.ijpddr.2017.11.003_bib17","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2017.11.003_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/1040-840291046713","article-title":"Current trends in research into the waterborne parasite Giardia","volume":"28","author":"Lane","year":"2002","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib19","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1021\/jacs.6b00299","article-title":"Using an old drug to target a new drug site: application of disulfiram to target the Zn-Site in HCV NS5A protein","volume":"138","author":"Lee","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s40475-015-0051-1","article-title":"Drug resistance in the microaerophilic parasite Giardia lamblia","volume":"2","author":"Leitsch","year":"2015","journal-title":"Curr. Trop. Med. Rep."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib21","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/prot.20097","article-title":"An unusual triosephosphate isomerase from the early divergent eukaryote Giardia lamblia","volume":"55","author":"L\u00f3pez-Vel\u00e1zquez","year":"2004","journal-title":"Proteins"},{"key":"10.1016\/j.ijpddr.2017.11.003_bib22","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.2174\/1568026616666160216153457","article-title":"The repurposing of old drugs or unsuccessful lead compounds by in silico approaches: new advances and perspectives","volume":"16","author":"Martorana","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib23","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1128\/AAC.42.6.1488","article-title":"Efficacies of zinc-finger-active drugs against Giardia lamblia","volume":"42","author":"Nash","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib24","first-page":"223","article-title":"The determination of triose phosphate isomerase","volume":"27","author":"Oesper","year":"1950","journal-title":"Arch. Biochem."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ddstr.2011.10.002","article-title":"Drug repurposing from an academic perspective","volume":"8","author":"Oprea","year":"2011","journal-title":"Drug. Discov. Today. Ther. Strateg."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib26","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1016\/S2214-109X(13)70078-0","article-title":"The drug and vaccine landscape for neglected diseases (2000-11): a systematic assessment","volume":"1","author":"Pedrique","year":"2013","journal-title":"Lancet. Glob. Health"},{"key":"10.1016\/j.ijpddr.2017.11.003_bib27","first-page":"343","article-title":"In vitro effect against Giardia of 14 plant extracts","volume":"46","author":"Ponce-Macotela","year":"1994","journal-title":"Rev. Invest. Clin."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib28","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.1128\/AAC.02900-14","article-title":"Giardial triosephosphate isomerase as possible target of the cytotoxic effect of omeprazole in Giardia lamblia","volume":"58","author":"Reyes-Vivas","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib29","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jmb.2006.10.053","article-title":"Disulfide bridges in the mesophilic triosephosphate isomerase from Giardia lamblia are related to oligomerization and activity","volume":"365","author":"Reyes-Vivas","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib30","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1124\/mol.65.3.675","article-title":"The molecular basis of the action of disulfiram as a modulator of the multidrug resistance-linked ATP binding cassette transporters MDR1 (ABCB1) and MRP1 (ABCC1)","volume":"65","author":"Sauna","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.pt.2006.02.015","article-title":"Giardia and Cryptosporidium join the 'neglected diseases initiative'","volume":"22","author":"Savioli","year":"2006","journal-title":"Trends. Parasitol."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib32","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.2174\/1568026616666160216154309","article-title":"Neglected tropical Protozoan diseases: drug repositioning as a rational option","volume":"16","author":"Sbaraglini","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib33","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1124\/mol.64.5.1076","article-title":"Inhibition of invasion and angiogenesis by zinc-chelating agent disulfiram","volume":"64","author":"Shian","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib34","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/S0140-6736(02)09096-7","article-title":"Drug development for neglected diseases: a deficient market and a public-health policy failure","volume":"359","author":"Trouiller","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2017.11.003_bib35","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bbrc.2006.01.003","article-title":"Disulfiram irreversibly aggregates betaine aldehyde dehydrogenase\u2013a potential target for antimicrobial agents against Pseudomonas aeruginosa","volume":"341","author":"Velasco-Garc\u00eda","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpddr.2017.11.003_bib36","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s11908-014-0396-y","article-title":"Treatment of giardiasis: current status and future directions","volume":"16","author":"Watkins","year":"2014","journal-title":"Curr. Infect. Dis. Rep."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221132071730101X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221132071730101X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:46:49Z","timestamp":1761922009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221132071730101X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S221132071730101X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2017.11.003","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disulfiram as a novel inactivator of Giardia lamblia triosephosphate isomerase with antigiardial potential","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2017.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}